Summary
Research Areas
Funds Available
| Predictor | Why It Matters | Evidence / CIHR Review Insights |
|---|---|---|
| Strong preliminary data and clear hypothesis | Reviewers emphasize feasibility and justification. | CIHR Project Grant reviewer guidelines. |
| Demonstrated research productivity | Publication record, especially as first or senior author, correlates highly with funding success. | CIHR bibliometric analyses (2019–2023). |
| Alignment with CIHR priority areas | Proposals linked to CIHR Institutes (e.g., Neurosciences, Infection, Chronic Disease) score higher for relevance. | Institute-specific funding reports. |
| Well-developed and feasible methodology | Detailed and realistic research design predicts reviewer confidence. | Reviewer score breakdowns (2021–2024). |
| Interdisciplinary and collaborative approach | Multi-institutional or cross-sector collaborations improve impact scores. | Tri-Agency evaluation reports. |
| Knowledge translation (KT) plan | CIHR uniquely weights KT and patient engagement (especially for applied research). | CIHR KT Framework (2020). |
| Strong trainee involvement and mentorship plan | Inclusion of HQP (highly qualified personnel) development is mandatory. | Application guidelines. |
| Equity, diversity, and inclusion (EDI) integration | Explicit discussion of EDI improves both merit and compliance. | CIHR EDI Policy (2023). |
| Institutional support and environment | Letters of support and infrastructure commitments strengthen feasibility. | Successful Project Grant examples. |
| Prior CIHR or Tri-Council funding record | Track record predicts future success (the “Matthew effect”). | CIHR Funding Success Study (2017–2022). |
Vague research question or poorly justified rationale.
Weak preliminary evidence or feasibility.
Overly ambitious scope or unfocused objectives.
Insufficient methodological detail or statistical plan.
Limited discussion of sex/gender or EDI considerations.
No clear KT or impact plan.
Minimal mentorship or trainee development detail.
Poor integration of interdisciplinary partners or collaborators.
| Category | Examples of High-Scoring Topics |
|---|---|
| Biomedical / Mechanistic | Genetic and molecular pathways of neurodegeneration, cancer signaling, immunometabolism. |
| Clinical / Translational | Personalized medicine, drug repurposing, real-world trials in oncology or rare disease. |
| Health Systems & Services | AI in diagnostic triage, equity in healthcare access, Indigenous health delivery models. |
| Population & Public Health | Climate-health interactions, vaccine acceptance, social determinants of chronic disease. |
| Interdisciplinary Initiatives | Digital health, One Health, microbiome-host interactions. |
Scientific excellence — solid hypothesis, rigorous design, strong preliminary data.
Productivity — recent first-/senior-author publications in relevant journals.
Feasibility — clear timeline, budget rationale, and achievable objectives.
Relevance to CIHR priorities — fit with at least one CIHR Institute.
Collaborative strength — co-investigators with complementary expertise.
Knowledge translation plan — clear strategy for dissemination and uptake.
Trainee development plan — explicit mentorship and training outcomes.
EDI and sex/gender analysis — integrated, not tokenistic.
Strong institutional support — facilities, co-funding, or infrastructure access.
Track record of prior CIHR or peer-reviewed funding.
Position: Assistant or associate professor (or postdoc for training awards).
Institution: Canadian university-affiliated research institute or hospital.
Track record: 5–10 peer-reviewed publications in last 5 years; prior CIHR/NSERC/SSHRC support or major fellowship.
Team composition: Multidisciplinary; often includes clinician-scientists and statisticians.
KT/EDI integration: Embedded in design, not appended.
“CRISPR-mediated gene repair for inherited retinal dystrophies.”
“Real-world effectiveness of telehealth in chronic pain management.”
“Microbiome–immune cross-talk in inflammatory bowel disease.”
“Improving equity in organ donation among Indigenous populations.”
“Machine learning models for early sepsis detection in Canadian ICUs.”
CIHR Project Grant success rate: ~18–21% overall (higher in biomedical fields).
~70% of successful PIs have at least one prior CIHR or Tri-Council award.
Publications per $100K CIHR funding: median 1.6 papers (2022 analysis).
Average 3–4 trainees supported per award.
Craft a tightly focused, hypothesis-driven proposal.
Embed feasibility through pilot data and clear milestones.
Integrate KT and EDI meaningfully.
Engage credible collaborators early.
Frame your impact in a Canadian health context.
Demonstrate training and mentorship potential.
Seek institutional letters showing infrastructure and sustainability.
Eligible Countries:
Sponsor Institute/Organizations: Canadian Institutes of Health Research
Sponsor Type: Corporate/Non-Profit
Address: 234 Laurier Avenue West Ottawa, Ontario K1A 0K9
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Nov 21, 2025
Nov 21, 2025
$28,567
CAD 40,000
Affiliation: Canadian Institutes of Health Research
Address: 234 Laurier Avenue West Ottawa, Ontario K1A 0K9
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.